Carbidopa (Amerigen Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Carbidopa drug offered from Amerigen Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amerigen Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Carbidopa
SUBSTANCE NAME: CARBIDOPA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-11-01
END MARKETING DATE: 0000-00-00


Carbidopa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCarbidopa from Amerigen Pharmaceuticals Inc.
LABELER NAME: Amerigen Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2013-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43975-220_c94d8749-b1fc-4b8d-b2aa-4d063f573254
PRODUCT NDC: 43975-220
APPLICATION NUMBER: ANDA203261

Other CARBIDOPA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Carbidopa Tablets, 25 mg
Amerigen Pharmaceuticals Inc.Carbidopa
Aton Pharma, IncLodosyn
Avera McKennan HospitalLodosyn
Edenbridge Pharmaceuticals LLCCarbidopa
Ingenus Pharmaceuticals NJ, LLCCARBIDOPA
KAISER FOUNDATION HOSPITALSLODOSYN
Oceanside PharmaceuticalsCarbidopa